| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | Common Stock | Options Exercise | $36.1K | +862 | +11.69% | $41.93 | 8.24K | Nov 2, 2021 | Direct | |
| transaction | CNMD | Common Stock | Sale | -$126K | -862 | -10.46% | $146.67 | 7.38K | Nov 2, 2021 | Direct | F1 |
| transaction | CNMD | Common Stock | Options Exercise | $306K | +5.1K | +69.15% | $59.96 | 12.5K | Nov 2, 2021 | Direct | |
| transaction | CNMD | Common Stock | Sale | -$268K | -1.82K | -14.61% | $147.06 | 10.7K | Nov 2, 2021 | Direct | F2 |
| transaction | CNMD | Common Stock | Sale | -$484K | -3.28K | -30.77% | $147.57 | 7.38K | Nov 2, 2021 | Direct | F3 |
| transaction | CNMD | Common Stock | Options Exercise | $142K | +1.8K | +24.41% | $78.76 | 9.18K | Nov 2, 2021 | Direct | |
| transaction | CNMD | Common Stock | Sale | -$137K | -928 | -10.11% | $147.51 | 8.25K | Nov 2, 2021 | Direct | F4 |
| transaction | CNMD | Common Stock | Sale | -$129K | -872 | -10.57% | $148.31 | 7.38K | Nov 2, 2021 | Direct | F5 |
| transaction | CNMD | Common Stock | Options Exercise | $166K | +1.7K | +23.05% | $97.69 | 9.08K | Nov 2, 2021 | Direct | |
| transaction | CNMD | Common Stock | Sale | -$253K | -1.7K | -18.73% | $148.60 | 7.38K | Nov 2, 2021 | Direct | F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -862 | -14.7% | $0.00 | 5K | Nov 2, 2021 | Common Stock | 862 | $41.93 | Direct | F7 |
| transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -5.1K | -32.08% | $0.00 | 10.8K | Nov 2, 2021 | Common Stock | 5.1K | $59.96 | Direct | F7 |
| transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -1.8K | -24% | $0.00 | 5.7K | Nov 2, 2021 | Common Stock | 1.8K | $78.76 | Direct | F8 |
| transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -1.7K | -18.28% | $0.00 | 7.6K | Nov 2, 2021 | Common Stock | 1.7K | $97.69 | Direct | F8 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.24 to $147.01. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.34 to $147.31. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.36 to $147.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.94 to $147.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.02 to $148.59. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.10 to $148.82. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F7 | The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
| F8 | The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |